Nilsine Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.03M | Sell |
72,917
-926
| -1% | -$63.9K | 0.51% | 41 |
|
|
2025
Q1 | $5.13M | Buy |
73,843
+3,102
| +4% | +$215K | 0.56% | 37 |
|
|
2024
Q4 | $6.09M | Buy |
70,741
+1,768
| +3% | +$152K | 0.65% | 30 |
|
|
2024
Q3 | $8.21M | Sell |
68,973
-338
| -0.5% | -$40.2K | 1.06% | 18 |
|
|
2024
Q2 | $9.89M | Sell |
69,311
-1,185
| -2% | -$169K | 1.33% | 16 |
|
|
2024
Q1 | $9.05M | Sell |
70,496
-930
| -1% | -$119K | 1.24% | 17 |
|
|
2023
Q4 | $7.39M | Sell |
71,426
-1,860
| -3% | -$192K | 1.14% | 18 |
|
|
2023
Q3 | $6.66M | Buy |
73,286
+968
| +1% | +$88K | 1.01% | 22 |
|
|
2023
Q2 | $5.85M | Buy |
72,318
+1,668
| +2% | +$135K | 0.86% | 25 |
|
|
2023
Q1 | $5.62M | Buy |
+70,650
| New | +$5.62M | 0.88% | 24 |
|